TEST BANK; Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 5th edition Woo Robinson. Chapter 1-55 Questions And Answers With Rationales in 244 Pages.

Pharmacotherapeutics mefor meAdvanced mePractice meNurse mePrescribers me5th meEdition meWoo meRobinson meTest
meBank




Chapter me1. meThe meRole meof methe meNurse

Practitioner meMultiple meChoice
me



Identify methe mechoice methat mebest mecompletes methe mestatement meor meanswers methe mequestion.

1. Nurse mepractitioner meprescriptive meauthority meis meregulated m e by:
1. The meNational meCouncil meof meState meBoards meof meNursing
2. The meU.S. meDrug meEnforcement meAdministration
3. The meState meBoard meof meNursing mefor meeach mestate
4. The meState meBoard meof mePharmacy

2. The mebenefits meto methe mepatient meof mehaving mean meAdvanced mePractice meRegistered meNurse me(APRN)
meprescriber meinclude:

1. Nurses meknow memore meabout mePharmacology methan meother meprescribers mebecause
methey metake meit meboth mein metheir mebasic menursing meprogram meand mein metheir meAPRN

meprogram.

2. Nurses mecare mefor methe mepatient mefrom mea meholistic meapproach meand meinclude methe
mepatient mein medecision memaking meregarding metheir mecare.

3. APRNs meare meless melikely meto meprescribe menarcotics meand meother mecontrolled mesubstances.
4. APRNs meare meable meto meprescribe meindependently mein meall mestates, mewhereas mea
mephysician’s meassistant meneeds meto mehave mea mephysician mesupervising metheir

mepractice.



3. Clinical mejudgment mein meprescribing m e includes:
1. Factoring mein methe mecost meto methe mepatient meof methe memedication meprescribed
2. Always meprescribing methe menewest memedication meavailable mefor methe medisease meprocess
3. Handing meout medrug mesamples meto mepoor mepatients
4. Prescribing meall megeneric memedications meto mecut mecosts
4. Criteria mefor mechoosing mean meeffective medrug mefor mea medisorder m einclude:
1. Asking methe mepatient mewhat medrug methey methink mewould mework mebest mefor methem
2. Consulting menationally merecognized meguidelines mefor medisease memanagement
3. Prescribing memedications methat meare meavailable meas mesamples mebefore mewriting mea meprescription
4. Following meU.S. meDrug meEnforcement meAdministration meguidelines mefor meprescribing
5. Nurse mepractitioner mepractice memay methrive meunder mehealth-care mereform mebecause meof:
1. The medemonstrated meability meof menurse mepractitioners meto mecontrol mecosts meand
meimprove mepatient meoutcomes

2. The mefact methat menurse mepractitioners mewill mebe meable meto mepractice meindependently
3. The mefact methat menurse mepractitioners mewill mehave mefull mereimbursement meunder
mehealth-care mereform

4. The meability meto meshift meaccountability mefor meMedicaid meto methe mestate melevel

,
,Chapter me1. meThe meRole meof methe meNurse
mePractitioner meAnswer meSection




MULTIPLE meCHOICE

1. ANS: m e me3 PTS: m e 1
2. ANS: m e me2 PTS: m e 1
3. ANS: m e me1 PTS: m e 1

4. ANS: m e me2 PTS: m e 1

5. ANS: m e me1 PTS: m e 1




Chapter me2. meReview meof meBasic mePrinciples meof mePharmacology

me Multiple meChoice
Identify methe mechoice methat mebest mecompletes methe mestatement meor meanswers methe mequestion.


m e 1. meA mepatient’s menutritional meintake meand melaboratory meresults mereflect mehypoalbuminemia. meThis
meis mecritical meto meprescribing mebecause:

1. Distribution meof medrugs meto metarget metissue memay mebe meaffected.
2. The mesolubility meof methe medrug mewill menot mematch methe mesite meof meabsorption.
3. There mewill mebe meless mefree medrug meavailable meto megenerate mean meeffect.
4. Drugs mebound meto mealbumin meare mereadily meexcreted meby methe mekidneys.
m e 2. meDrugs methat mehave mea mesignificant mefirst-pass m e effect:
1. Must mebe megiven meby methe meenteral me(oral) meroute meonly
2. Bypass methe mehepatic mecirculation
3. Are merapidly memetabolized meby methe meliver meand memay mehave melittle meif meany medesired meaction
4. Are meconverted meby methe meliver meto memore meactive meand mefat-soluble meforms
m e m e 3. meThe meroute meof meexcretion meof mea mevolatile medrug mewill melikely mebe m e the:
1. Kidneys
2. Lungs
3. Bile meand mefeces
4. Skin

m e 4. meMedroxyprogesterone me(Depo meProvera) meis meprescribed meintramuscularly me(IM) meto mecreate
mea mestorage mereservoir meof methe medrug. meStorage mereservoirs:

1. Assure methat methe medrug mewill mereach meits meintended metarget metissue
2. Are methe mereason mefor megiving meloading medoses
3. Increase methe melength meof metime mea medrug meis meavailable meand meactive
4. Are memost mecommon mein mecollagen metissues
m e m e 5. meThe meNP mechooses meto megive mecephalexin meevery me8 mehours mebased meon meknowledge meof methe m e drug’s:
1. Propensity meto mego meto methe metarget mereceptor
2. Biological mehalf-life
3. Pharmacodynamics
4. Safety meand meside meeffects

, m e 6. meAzithromycin medosing merequires methat methe mefirst meday’s medosage mebe metwice methose meof methe
meother me4 medays meof methe meprescription. meThis meis meconsidered mea meloading medose. meA meloading

medose:

1. Rapidly meachieves medrug melevels mein methe metherapeutic merange
2. Requires mefour- meto mefive-half-lives meto meattain
3. Is meinfluenced meby merenal mefunction
4. Is medirectly merelated meto methe medrug mecirculating meto methe metarget metissues

m e 7. meThe mepoint mein metime meon methe medrug meconcentration mecurve methat meindicates methe mefirst mesign meof mea
metherapeutic meeffect meis methe:

1. Minimum meadverse meeffect melevel
2. Peak meof meaction